Ep135: John Maraganore on Developing a New Class of Medicines
The Long Run with Luke Timmerman
00:00
Pharma exodus and focus on liver targets
John explains pharma pullback from RNAi, why oncology failed, and pivoting to liver targets with strong human genetics.
Play episode from 28:20
Transcript
